FIELD: medicine.
SUBSTANCE: offered medicinal agent is applied for brain dopamine receptors modulation at menopause - phemoston. It is shown that at menopause and after ovariectomy brain dopamine receptors affinity and density is increased.
EFFECT: specified parameters are decreased for rats to intact animal level.
2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG FOR MODULATION OF H2-HISTAMINE HEART RECEPTORS DENSITY DURING MENOPAUSE | 2007 |
|
RU2332219C1 |
| COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING MENOPAUSAL SYNDROME IN FEMALES, CONTAINING LOGANIN OR DERIVATIVES THEREOF AS AN ACTIVE INGREDIENT | 2017 |
|
RU2697672C1 |
| AGENT EXHIBITING ANTIPSYCHOTIC ACTIVITY | 2008 |
|
RU2411248C2 |
| USING BELAMCANDA CHINENSIS EXTRACT AS ESTROGEN-LIKE ORGAN-SELECTIVE MEDICINAL PREPARATION WITHOUT UTEROTROPIC EFFECT | 1999 |
|
RU2263505C2 |
| APPLICATION OF EXTRACTS OF FAMILY IRIDACEAE AND CIMICIFUGA RACEMOSA AND TECTORIGENIN AS ORGAN-SELECTIVE MEDICINAL PREPARATION WITHOUT UTEROTROPIC EFFECT ACTING BY ESTROGEN-LIKE TYPE | 1999 |
|
RU2228188C2 |
| METHOD OF MASS INCREASE TREATMENT AND/OR INHIITION | 2000 |
|
RU2327461C2 |
| NEUROTROPIC DRUG AND METHOD OF TREATING STRUCTURAL DISEASES OF NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHIES OF VARIOUS ORIGINS | 2011 |
|
RU2536234C2 |
| METHODS OF TREATING AND/OR SUPPRESSING WEIGHT GROWTH | 2000 |
|
RU2519642C2 |
| AGENT FOR TREATMENT AND PREVENTION OF PARKINSON'S DISEASE | 2006 |
|
RU2324492C1 |
| SUBSTITUTED BENZOXAZOLES AND THEIR ANALOGUES AS OESTROGEN AGENTS | 2002 |
|
RU2330847C2 |
